My price targets for $NWBO: PR of MHRA submission/acceptance - $1.21 Announcement of MHRA approval - $3.87 FDA approval or buyout - $22.00 NOT investment advice.

$FNGR $9.00+ and a new 52 week high this week? I find it VERY interesting higher strike call options ($12, $13) were just added over the weekend. VERY BULLISH! (Not investment advice)

$FNGR and Univest Securities?!?!? Take a look at the track record of Univest- if the chatter was active about a SHORT SQUEEZE before this S-3, then...just...wow... I'm generally not a fan of the term M.O.A.S.S. - but...

Giving shorts the $FNGR. Enough said.

$NWBO will be able to treat Grade IV newly diagnosed & recurrent GBM with #DCVax-L & also Grade III malignant brain tumors. This will effectively double addressable market size. Also biomarker & proteomics analysis is good for tissue agnostic approvals: investorshub.advfn.com/boards/read_ms…

The numbers are are some of the most impressive I HAVE EVER SEEN. This bodes EXTREMELY WELL for cancer treatment! Be careful- if this gets out, people may actually start to realize the TRUE value of $NWBO and #DCVax!

Tonight we heard a recording of $NWBO Les Goldman on the Big Biz Show. I recommend readers listen to him (link below). From minutes 25-35 approximately. He will be on the show next week too. The discussion was about how prominent the journal JAMA Oncology was, that four

We are within about 15 days of a BIG catalyst for $NWBO- but there's several I can see coming down the pipe in the coming weeks/months!

Sticking to my price targets for now! $NWBO

$NWBO inbound catalysts are about to annihilate some shorts, it appears! #DCVax The clock is ticking. October is going to be an EXCITING month!

Excitement building for $NWBO and #DCVax - MAA submission likely within the next 2 weeks, Dr. Linda Liau on the SAB - LOTS of short term positive catalysts for this one! Don't take my word for it: jamanetwork.com/journals/jamao…

We are now WITHIN that 30-45 day window! $NWBO "The Company anticipates submitting the MAA in approximately the next 30-45 days. The Company plans to request that the MHRA review the MAA under the 150-business day process..." prnewswire.com/news-releases/…

$FNGR 👀👀👀

Looks like $FNGR is about to give THE finger to the shorts.

Looks like it's about to be a PAINFUL weekend for the shorts in $FNGR.

I predict that $NWBO market cap passes $NVCR market cap in 2023. I predict that $NWBO share price passes $NVCR share price in 2024. Not investment advice.

Shorts in $FNGR:

On the watch list for this week: $NWBO $FNGR 👀

INCREDIBLY good news for $NWBO from their 10-Q in my opinion- it sounds as if MHRA approval is just around the corner! #DCVax

Let's GO $FNGR!